Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |